Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Molecules ; 28(5)2023 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-36903631

RESUMO

INTRODUCTION: Medulloblastoma (MB) is the most common malignant tumor of the central nervous system in childhood. FTIR spectroscopy provides a holistic view of the chemical composition of biological samples, including the detection of molecules such as nucleic acids, proteins, and lipids. This study evaluated the applicability of FTIR spectroscopy as a potential diagnostic tool for MB. MATERIALS AND METHODS: FTIR spectra of MB samples from 40 children (boys/girls: 31/9; age: median 7.8 years, range 1.5-21.5 years) treated in the Oncology Department of the Children's Memorial Health Institute in Warsaw between 2010 and 2019 were analyzed. The control group consisted of normal brain tissue taken from four children diagnosed with causes other than cancer. Formalin-fixed and paraffin-embedded tissues were sectioned and used for FTIR spectroscopic analysis. The sections were examined in the mid-infrared range (800-3500 cm-1) by ATR-FTIR. Spectra were analysed using a combination of principal component analysis, hierarchical cluster analysis, and absorbance dynamics. RESULTS: FTIR spectra in MB were significantly different from those of normal brain tissue. The most significant differences related to the range of nucleic acids and proteins in the region 800-1800 cm-1. Some major differences were also revealed in the quantification of protein conformations (α-helices, ß-sheets, and others) in the amide I band, as well as in the absorbance dynamics in the 1714-1716 cm-1 range (nucleic acids). It was not, however, possible to clearly distinguish between the various histological subtypes of MB using FTIR spectroscopy. CONCLUSIONS: MB and normal brain tissue can be distinguished from one another to some extent using FTIR spectroscopy. As a result, it may be used as a further tool to hasten and enhance histological diagnosis.


Assuntos
Neoplasias Cerebelares , Meduloblastoma , Ácidos Nucleicos , Masculino , Criança , Feminino , Humanos , Lactente , Pré-Escolar , Adolescente , Adulto Jovem , Adulto , Espectroscopia de Infravermelho com Transformada de Fourier/métodos , Proteínas
2.
Med Wieku Rozwoj ; 7(2): 249-60, 2003.
Artigo em Polonês | MEDLINE | ID: mdl-12878796

RESUMO

UNLABELLED: THE AIM of this study was to estimate the value of HMRS in the diagnosis of brain lesions observed in children treated with chemo and radiotherapy and to assess the possibility to differentiate these lesions from neoplasm or recurrent disease. MATERIALS AND METHOD: We examined 6 children, aged from 7 to 15 yrs, 3 with brain tumours, 1 with esthesioneuroblastoma treated with chemo and radiotherapy and 2 patients with chemotherapy only, for other neoplasms (leukemia, Wilms tumor). Indications to perform imaging studies were routine for brain tumour patients (no clinical symptoms) and suspicion of disease recurrence in others. MR with 1.5 T scanner and additionally single voxel HMRS in PRESS sequence were performed. RESULTS: In all cases MRI showed extensive hyperintensive changes in brain tissue with significant mass effect. In 3 cases HMRS was within normal limits, in other 3 cases moderately elevated peak of choline and peak of lactate and lipids were found. In follow up examinations all lesions regressed and all patients are in good clinical condition. COMMENTS: It could be difficult to differentiate white matter injury from malignancies on MRI. HMRS in case of doubtful findings on MRI in children treated with chemo and radiotherapy, especially in those without symptoms of their disease, is a helpful method.


Assuntos
Encéfalo/patologia , Imageamento por Ressonância Magnética , Espectroscopia de Ressonância Magnética , Lesões por Radiação/diagnóstico , Adolescente , Adulto , Encéfalo/efeitos dos fármacos , Encéfalo/efeitos da radiação , Quimioterapia Adjuvante/efeitos adversos , Criança , Terapia Combinada , Diagnóstico Diferencial , Estesioneuroblastoma Olfatório/tratamento farmacológico , Estesioneuroblastoma Olfatório/radioterapia , Feminino , Seguimentos , Humanos , Leucemia/tratamento farmacológico , Leucemia/radioterapia , Masculino , Recidiva Local de Neoplasia/diagnóstico , Neoplasias Nasais/tratamento farmacológico , Neoplasias Nasais/radioterapia , Polônia , Prótons , Lesões por Radiação/etiologia , Radioterapia Adjuvante/efeitos adversos , Sensibilidade e Especificidade , Fatores de Tempo , Tumor de Wilms/tratamento farmacológico , Tumor de Wilms/radioterapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA